nasal phage therapy (Novolytics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namenasal phage therapy (Novolytics)
Drug Alias NameNVL-005
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWounds and InjuriesBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovolytics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovolytics Ltd
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A